Adicet Bio Company

Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer
Technology: Cell-based gene therapy
Industry: Longevity, Private
Headquarters: Redwood City, California, United States
Founded Date: 2014-01-01
Employees Number: 101-250
Investors Number: 7
Total Funding: 145625000
Estimated Revenue: $10M to $50M
Last Funding Date: 2022-08-08
Last Funding Type: Post-IPO Equity

Visit Website
ir@adicetbio.com
Register and Claim Ownership